PHARMAFILM Trademark

Trademark Overview


On Tuesday, July 24, 2007, a trademark application was filed for PHARMAFILM with the United States Patent and Trademark Office. The USPTO has given the PHARMAFILM trademark a serial number of 77237564. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, May 6, 2008. This trademark is owned by Akela Pharma Inc.. The PHARMAFILM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system; Pharmaceutical preparations and substances for use in pain control and pain management, arthritis, anesthesia, asthma, oncology, urology, gynecology; Pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; Pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases and arthritis; Pharmaceutical preparations and substances for the treatment and prevention of diabetes; Chemicals relating to drug performance and/or drug delivery performance for research use and manufacturing in the biotechnical, biomedical and pharmaceutical industries; Inhalers and applicators for the prevention and treatment of diseases and disord...
pharmafilm

General Information


Serial Number77237564
Word MarkPHARMAFILM
Filing DateTuesday, July 24, 2007
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, May 6, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system; Pharmaceutical preparations and substances for use in pain control and pain management, arthritis, anesthesia, asthma, oncology, urology, gynecology; Pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; Pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases and arthritis; Pharmaceutical preparations and substances for the treatment and prevention of diabetes; Chemicals relating to drug performance and/or drug delivery performance for research use and manufacturing in the biotechnical, biomedical and pharmaceutical industries; Inhalers and applicators for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system; Inhalers and applicators for use in pain control, asthma treatment, arthritis, anesthesia, oncology, infection, inflammation, urology, gynecology, dental care, surgery and radiology; Inhalers and applicators for the treatment and prevention of diabetes; Apparatus and instruments for use in pain control and pain management, arthritis, asthma, anesthesia, oncology, infection, inflammation, urology, gynecology, dental care, surgery respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system and radiology; apparatus and instruments for the treatment and prevention of diabetes; prepared and processed proteins and myco-proteins for human consumption; Medical devices, namely, medical apparatus, namely, a unit for aerosol drug delivery to the deep lung of drugs as fine, dry particles; Chemicals for use in the manufacture of pharmaceuticals, namely, peptides, polypeptides, molecules, enzymes substrates, natural extracts, active principles, reactives, solvents, metals, metalloids; chemicals for use in the manufacture of cosmetics; Pharmaceutical, veterinary and sanitary preparations and dietetic substances adapted for medical use, namely, psychotropic, cardiovascular agents, vasotherapeutics in the form of ampoule, tablets or liquid, anti-infective, antibiotics, chemotherapeutics, antiviral agents, hormones, metabolic agents in the form of caplets or liquid or particulate inhaleable formulation, namely, peptides, polypeptides, opiods, opiod derivatives, pain agents, amino acids, peptides, creatine, dextrose, vitamin C, antidiabetic drugs, agents for digestive disorders, namely, antiacids, anti-diarrhea and antiemetics in the form of liquid or caplets, antiallergic drugs, analgesics, spasmolytic drugs, narcotics, anesthetics, antiphlogistic, antirheumatic and anti asthmatic agents; Dermatological preparations, namely, creams for the treatment of pain, acne, eczema, dry skin, psoriasis and other immune system controlling agents, namely, vaccines, drugs to treat osteoporosis, tumor therapeutics; Biological products, namely, for pharmaceutical, clinical or medical laboratory use, namely, biological reagents for diagnostic and scientific purposes, antiemetics, pain treatment drugs, vaccines, infusions of said drugs; Plasters, namely, material plasters, adhesive plasters, mucosa plasters, drug bearing plasters and films, materials for dressings; material for stopping teeth: Surgical, medical, dental and veterinary apparatus and instruments, namely, aerosol dispensers for medical purposes, injectors for medical purposes, pumps for medical purposes; tissues and materials impregnated with pharmaceutical substances, namely, opiod bearing films; Pharmaceutical and veterinary products in the form of caplets, liquid to be administrated by injection, liquid to be orally administrated for the prevention and treatment of obesity, smoking cessation, nephropathy, pulmonary embolism, atherothrombosis, asthma, hypertension, thrombosis, arrhythmia, angina, hypertension, heart failure, insomnia, epilepsy, schizophrenia, fever and pain; Pharmaceutical preparations for the treatment of the central nervous system, namely, neurotic and psychosomatic disorder, namely, anxiety, depression, hysteria, stress, fears; prostatic hyperplasia, granuloma inguinale, bilharziasis, and other protozoal infections, namely, babesios, coccidiosis, cryptosporidiosis, malaria, toxoplasmosis, trichomoniasis, trypanosomiasis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 27, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAkela Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSaint-Laurent, Quebec H4R2N1
CA

Trademark Events


Event DateEvent Description
Wednesday, May 7, 2008ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, May 6, 2008ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, December 18, 2007APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 18, 2007ASSIGNED TO LIE
Tuesday, November 6, 2007PAPER RECEIVED
Tuesday, October 9, 2007NON-FINAL ACTION MAILED
Tuesday, October 9, 2007NON-FINAL ACTION WRITTEN
Tuesday, October 2, 2007ASSIGNED TO EXAMINER
Friday, July 27, 2007NEW APPLICATION ENTERED IN TRAM